Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells
There is a need for agents that eliminate cancer stem cells, which sustain cancer and are also largely responsible for disease relapse and metastasis. Conventional chemotherapeutics and radiotherapy are often highly effective against the bulk of cancer cells, which are proliferating, but spare cance...
Main Author: | Geoffrey Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/9/4814 |
Similar Items
-
The RARγ Oncogene: An Achilles Heel for Some Cancers
by: Geoffrey Brown, et al.
Published: (2021-03-01) -
Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells
by: Geoffrey Brown
Published: (2023-01-01) -
Understanding the Action of RARγ Agonists on Human Osteochondroma Explants
by: Sonia A. Garcia, et al.
Published: (2020-04-01) -
RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells
by: Amanda Dabrock, et al.
Published: (2023-11-01) -
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
by: Kohei Yamakawa, et al.
Published: (2023-05-01)